封面
市场调查报告书
商品编码
1534252

全球心血管修復和重建设备市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Cardiovascular Repair and Reconstruction Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

全球心血管修復和重建设备市场需求预计将从2023年的43.9亿美元达到2032年近73.3亿美元的市场规模,2024-2032年研究期间的复合年增长率为5.86%。

心血管修復和重建设备包括一系列用于透过手术介入治疗心血管疾病 (CVD) 的医疗工具和植入物。这些设备旨在修復或重建患病或受损的心臟瓣膜、动脉和其他心臟结构,恢復正常的心臟功能并改善整体心血管健康。这些设备旨在修復或重建受损或患病的心臟瓣膜、动脉和其他心臟结构,从而恢復正常的心臟功能并增强整体心血管健康。常见的装置包括人工心臟瓣膜、支架、心律调节器、除颤器和心臟贴片。它们对于管理冠状动脉疾病、心臟瓣膜缺陷、心律不整和先天性心臟缺陷等疾病至关重要,为患者提供治疗和预防干预措施的选择,以减轻与心血管疾病相关的风险。

市场动态

心血管疾病的流行和医疗技术的进步推动了心血管修復和重建设备市场。由于人口老化和生活方式的改变,全球心血管疾病负担日益加重,增加了对提供微创治疗选择和改善患者治疗效果的创新设备的需求。设备材料、设计和植入技术方面的技术进步提高了设备性能、耐用性以及与患者生理的兼容性。此外,全球医疗保健支出和心血管护理基础设施投资的增加为心血管修復和重建设备市场的扩张提供了巨大的成长机会。政府和医疗保健提供者优先考虑采用先进的心血管设备,以解决与心血管疾病管理和住院相关的不断上升的医疗成本。此外,提高心血管疾病早期检测意识和筛检计画也有助于市场成长。关于心血管设备使用的患者教育措施和医生培训也支持市场渗透率和采用率,特别是在心血管护理机会正在改善的新兴市场。此外,医疗器材製造商、研究机构和医疗保健提供者之间的策略合作推动了心血管修復和重建领域的创新和产品开发。对研究和临床试验的投资以验证新设备的功效和安全性,进一步刺激市场成长和多元化。然而,新型心血管设备严格的监管审批流程和报销挑战对心血管修復和重建设备的市场成长构成了障碍。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球心血管修復和重建设备市场的各个细分市场进行了包容性评估。心血管修復和重建设备产业的成长和趋势为本研究提供了整体方法。

市场区隔

心血管修復和重建设备市场报告的这一部分提供了国家和地区层面细分市场的详细资料,从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

  • 心臟瓣膜修復
  • 心血管移植物(血管内支架移植、血液透析通路移植物、週边血管移植物)
  • 心血管补片(依应用分类(心臟修补补片(心房中隔缺损、共心房、心内膜垫缺损、室间隔缺损、法洛氏四合症、缝线出血)、血管修补补片(颈动脉内膜切除术、肺静脉异常连接、运输)大血管的重建、门静脉和肠系膜上静脉的重建、其他)(依原料分类(合成补片、生物补片)

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲心血管修復和重建设备市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。心血管修復和重建设备市场的主要参与者包括美敦力、巴德週边血管、泰尔茂心血管系统公司、WL Gore & Associates Inc.、Getinge AB、CryoLife Inc.、Edwards Lifesciences Corporation。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:心血管修復和重建设备 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球心血管修復与重建设备市场分析:按产品

  • 概述(按产品)
  • 按产品分类的历史和预测资料分析
  • 心臟瓣膜修復
  • 心血管移植物(血管内支架移植、血液透析通路移植物、週边血管移植物)
  • 心血管补片(依应用分类(心臟修补补片(心房中隔缺损、共心房、心内膜垫缺损、室间隔缺损、法洛氏四合症、缝线出血)、血管修补补片(颈动脉内膜切除术、肺静脉异常连接、运输)大血管的重建、门静脉及肠系膜上静脉的重建、其他)(依原料分类(合成补片、生物补片)

第 6 章:全球心血管修復与重建设备市场分析:依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 7 章:心血管修復与重建设备公司的竞争格局

  • 心血管修復重建器材市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 8 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Medtronic
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bard Peripheral Vascular
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Terumo Cardiovascular Systems Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • WL Gore & Associates Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Getinge AB
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • CryoLife Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Edwards Lifesciences Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中,财务详细资讯和最新发展视情况而定,或对私人公司而言可能不包括在内

Product Code: VMR112115293

The global demand for Cardiovascular Repair and Reconstruction Devices Market is presumed to reach the market size of nearly USD 7.33 Billion by 2032 from USD 4.39 Billion in 2023 with a CAGR of 5.86% under the study period 2024-2032.

Cardiovascular repair and reconstruction devices encompass a range of medical tools and implants used to treat cardiovascular diseases (CVDs) through surgical interventions. These devices are designed to repair or rebuild diseased or damaged heart valves, arteries, and other cardiac structures, restoring normal heart function and improving overall cardiovascular health. These devices are created to mend or rebuild damaged or diseased heart valves, arteries, and other cardiac structures, thereby restoring normal heart function and enhancing overall cardiovascular health. Common devices include prosthetic heart valves, stents, pacemakers, defibrillators, and cardiac patches. They are essential in managing conditions such as coronary artery disease, heart valve defects, arrhythmias, and congenital heart defects, offering patients options for both therapeutic and preventive interventions to mitigate the risks associated with CVDs.

MARKET DYNAMICS

The propelling prevalence of cardiovascular diseases and advancements in medical technology drives the cardiovascular repair and reconstruction devices market. The growing global burden of CVDs, fuelled by aging populations and lifestyle changes, amplifies demand for innovative devices that offer minimally invasive treatment options and improved patient outcomes. Technological advancements in device materials, design, and implantation techniques enhance device performance, durability, and compatibility with patient physiology. Moreover, rising healthcare expenditures and investments in cardiovascular care infrastructure worldwide provide significant growth opportunities for the expansion of the cardiovascular repair and reconstruction devices market. Governments and healthcare providers prioritize adopting advanced cardiovascular devices to address the escalating healthcare costs associated with CVD management and hospitalizations. Furthermore, increasing awareness and screening programs for early detection of cardiovascular conditions contribute to market growth. Patient education initiatives and physician training in the use of cardiovascular devices also support market penetration and adoption rates, particularly in emerging markets where access to cardiovascular care is improving. Additionally, strategic collaborations between medical device manufacturers, research institutions, and healthcare providers drive innovation and product development in the cardiovascular repair and reconstruction sector. Investments in research and clinical trials to validate the efficacy and safety of new devices further stimulate market growth and diversification. However, stringent regulatory approval processes and reimbursement challenges for new cardiovascular devices pose barriers to market growth for cardiovascular repair and reconstruction devices.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cardiovascular Repair and Reconstruction Devices. The growth and trends of Cardiovascular Repair and Reconstruction Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cardiovascular Repair and Reconstruction Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Heart Valve Repair
  • Cardiovascular Grafts (Endovascular Stent Graft, Hemodialysis Access Graft, Peripheral Vascular Graft)
  • Cardiovascular Patches (by Application (Cardiac Repair Patches (Atrial Septal Defect, Common Atrium, Defects of The Endocardial Cushion, Ventricular Septal Defect, Tetralogy of Fallot, Suture Bleeding), Vascular Repair Patches (Carotid Endarterectomy, Anomalous Connection of The Pulmonary Veins, Transportation of The Great Vessels, Reconstruction of The Portal and Superior Mesenteric Veins, Others) (by Raw Material (Synthetic Patches, Biological Patches)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cardiovascular Repair and Reconstruction Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cardiovascular Repair and Reconstruction Devices market include Medtronic, Bard Peripheral Vascular, Terumo Cardiovascular Systems Corporation, W. L. Gore & Associates Inc., Getinge AB, CryoLife Inc., Edwards Lifesciences Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CARDIOVASCULAR REPAIR AND RECONSTRUCTION DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CARDIOVASCULAR REPAIR AND RECONSTRUCTION DEVICES MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Heart Valve Repair Historic and Forecast Sales By Regions
  • 5.4. Cardiovascular Grafts (Endovascular Stent Graft, Hemodialysis Access Graft, Peripheral Vascular Graft) Historic and Forecast Sales By Regions
  • 5.5. Cardiovascular Patches (by Application (Cardiac Repair Patches (Atrial Septal Defect, Common Atrium, Defects of The Endocardial Cushion, Ventricular Septal Defect, Tetralogy of Fallot, Suture Bleeding), Vascular Repair Patches (Carotid Endarterectomy, Anomalous Connection of The Pulmonary Veins, Transportation of The Great Vessels, Reconstruction of The Portal and Superior Mesenteric Veins, Others) (by Raw Material (Synthetic Patches, Biological Patches) Historic and Forecast Sales By Regions

6. GLOBAL CARDIOVASCULAR REPAIR AND RECONSTRUCTION DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 6.1. Regional Outlook
  • 6.2. Introduction
  • 6.3. North America Sales Analysis
    • 6.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.3.2 North America By Segment Sales Analysis
    • 6.3.3 North America By Country Sales Analysis
    • 6.3.4 United States Sales Analysis
    • 6.3.5 Canada Sales Analysis
    • 6.3.6 Mexico Sales Analysis
  • 6.4. Europe Sales Analysis
    • 6.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.4.2 Europe By Segment Sales Analysis
    • 6.4.3 Europe By Country Sales Analysis
    • 6.4.4 United Kingdom Sales Analysis
    • 6.4.5 France Sales Analysis
    • 6.4.6 Germany Sales Analysis
    • 6.4.7 Italy Sales Analysis
    • 6.4.8 Russia Sales Analysis
    • 6.4.9 Rest Of Europe Sales Analysis
  • 6.5. Asia Pacific Sales Analysis
    • 6.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.5.2 Asia Pacific By Segment Sales Analysis
    • 6.5.3 Asia Pacific By Country Sales Analysis
    • 6.5.4 China Sales Analysis
    • 6.5.5 India Sales Analysis
    • 6.5.6 Japan Sales Analysis
    • 6.5.7 South Korea Sales Analysis
    • 6.5.8 Australia Sales Analysis
    • 6.5.9 South East Asia Sales Analysis
    • 6.5.10 Rest Of Asia Pacific Sales Analysis
  • 6.6. Latin America Sales Analysis
    • 6.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.6.2 Latin America By Segment Sales Analysis
    • 6.6.3 Latin America By Country Sales Analysis
    • 6.6.4 Brazil Sales Analysis
    • 6.6.5 Argentina Sales Analysis
    • 6.6.6 Peru Sales Analysis
    • 6.6.7 Chile Sales Analysis
    • 6.6.8 Rest of Latin America Sales Analysis
  • 6.7. Middle East & Africa Sales Analysis
    • 6.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.7.2 Middle East & Africa By Segment Sales Analysis
    • 6.7.3 Middle East & Africa By Country Sales Analysis
    • 6.7.4 Saudi Arabia Sales Analysis
    • 6.7.5 UAE Sales Analysis
    • 6.7.6 Israel Sales Analysis
    • 6.7.7 South Africa Sales Analysis
    • 6.7.8 Rest Of Middle East And Africa Sales Analysis

7. COMPETITIVE LANDSCAPE OF THE CARDIOVASCULAR REPAIR AND RECONSTRUCTION DEVICES COMPANIES

  • 7.1. Cardiovascular Repair and Reconstruction Devices Market Competition
  • 7.2. Partnership/Collaboration/Agreement
  • 7.3. Merger And Acquisitions
  • 7.4. New Product Launch
  • 7.5. Other Developments

8. COMPANY PROFILES OF CARDIOVASCULAR REPAIR AND RECONSTRUCTION DEVICES INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Market Concentration Rate
  • 8.3. Medtronic
    • 8.3.1 Company Overview
    • 8.3.2 Company Revenue
    • 8.3.3 Products
    • 8.3.4 Recent Developments
  • 8.4. Bard Peripheral Vascular
    • 8.4.1 Company Overview
    • 8.4.2 Company Revenue
    • 8.4.3 Products
    • 8.4.4 Recent Developments
  • 8.5. Terumo Cardiovascular Systems Corporation
    • 8.5.1 Company Overview
    • 8.5.2 Company Revenue
    • 8.5.3 Products
    • 8.5.4 Recent Developments
  • 8.6. W. L. Gore & Associates Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Company Revenue
    • 8.6.3 Products
    • 8.6.4 Recent Developments
  • 8.7. Getinge AB
    • 8.7.1 Company Overview
    • 8.7.2 Company Revenue
    • 8.7.3 Products
    • 8.7.4 Recent Developments
  • 8.8. CryoLife Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Company Revenue
    • 8.8.3 Products
    • 8.8.4 Recent Developments
  • 8.9. Edwards Lifesciences Corporation
    • 8.9.1 Company Overview
    • 8.9.2 Company Revenue
    • 8.9.3 Products
    • 8.9.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Heart Valve Repair Market Sales By Geography (USD MN)
  • Cardiovascular Grafts (Endovascular Stent Graft, Hemodialysis Access Graft, Peripheral Vascular Graft) Market Sales By Geography (USD MN)
  • Cardiovascular Patches (by Application (Cardiac Repair Patches (Atrial Septal Defect, Common Atrium, Defects of The Endocardial Cushion, Ventricular Septal Defect, Tetralogy of Fallot, Suture Bleeding), Vascular Repair Patches (Carotid Endarterectomy, Anomalous Connection of The Pulmonary Veins, Transportation of The Great Vessels, Reconstruction of The Portal and Superior Mesenteric Veins, Others) (by Raw Material (Synthetic Patches, Biological Patches) Market Sales By Geography (USD MN)
  • Global Cardiovascular Repair and Reconstruction Devices Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cardiovascular Repair and Reconstruction Devices Report
  • Market Research Process
  • Market Research Methodology
  • Global Cardiovascular Repair and Reconstruction Devices Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Heart Valve Repair Market Sales By Geography (USD MN)
  • Cardiovascular Grafts (Endovascular Stent Graft, Hemodialysis Access Graft, Peripheral Vascular Graft) Market Sales By Geography (USD MN)
  • Cardiovascular Patches (by Application (Cardiac Repair Patches (Atrial Septal Defect, Common Atrium, Defects of The Endocardial Cushion, Ventricular Septal Defect, Tetralogy of Fallot, Suture Bleeding), Vascular Repair Patches (Carotid Endarterectomy, Anomalous Connection of The Pulmonary Veins, Transportation of The Great Vessels, Reconstruction of The Portal and Superior Mesenteric Veins, Others) (by Raw Material (Synthetic Patches, Biological Patches) Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.